D Rhamnose β-hederin Reverses NAP1L5- mediated Adriamycin Resistance in Breast Cancer.
| Publicado en: | Alternative Therapies in Health & Medicine Vol. 29; no. 3; pp. 127 - 134 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
InnoVisions Professional Media
Apr2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163171968&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 163171968 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10786791 88C jtl: Alternative Therapies in Health & Medicine issn: 10786791 maglogo: N pubinfo: dt: Apr2023 vid: 29 iid: 3 pid: 65582 pub: InnoVisions Professional Media place: Eagan, Minnesota artinfo: ui: 163171968 163171968 ppf: 127 ppct: 7 formats: fmt: @attributes: type: P tig: atl: D Rhamnose β-hederin Reverses NAP1L5- mediated Adriamycin Resistance in Breast Cancer. aug: au: Ling-Yun Xu Qi Qian Xiao He Jing-Yi Wang Lin Cheng affil: Department of Breast Surgery, the Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, Changzhou, China. sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|